Related Experiment Video
Updated: Jan 11, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Neuropsychiatric systemic lupus erythematosus - current and novel treatments
Rohan Gupta1, Maeva Agapoff2, Betty Diamond2
1Barbara and Donald Zucker School of Medicine, Hempstead.
Purpose Of Review:
Here, we provide a broad overview of the current treatment landscape of neuropsychiatric systemic lupus erythematosus (NPSLE) focusing on diffuse central nervous system manifestations and potential new treatments based on studies of murine models and neuroimaging studies of patients.
Recent Findings:
The therapeutic landscape focuses on three approaches: modulation of B cell activity and circulating autoantibodies (CAR-T cell and BTK inhibitor therapies), reduction of systemic inflammation (JAK, TYK2, and anti-IFN inhibitors), and direct neuroprotection (ACE inhibitors and ARBs).
Summary:
These findings broaden the therapeutic landscape for NPSLE beyond general immunosuppression. Future research must prioritize clinical trials inclusive of NPSLE patients to validate these promising strategies.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents
Alzheimer's Disease: Treatment
Psychosis: Goals of Pharmacotherapy
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...

